Canada markets open in 8 hours 30 minutes

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.28-0.83 (-1.84%)
At close: 04:00PM EDT
44.98 +0.70 (+1.58%)
After hours: 04:36PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
434,249
434,249
363,329
351,406
271,030
Cost of Revenue
45,209
45,209
28,320
16,008
6,129
Gross Profit
389,040
389,040
335,009
335,398
264,901
Operating Expenses
Research Development
648,449
648,449
705,789
497,153
412,084
Selling General and Administrative
309,799
309,799
278,139
219,982
182,933
Total Operating Expenses
958,248
958,248
983,928
717,135
595,017
Operating Income or Loss
-569,208
-569,208
-648,919
-381,737
-330,116
Interest Expense
66,004
66,004
43,015
29,422
33,291
Total Other Income/Expenses Net
60
60
-20,865
-43,750
171,010
Income Before Tax
-608,464
-608,464
-701,725
-452,981
-185,359
Income Tax Expense
-1,825
-1,825
5,696
1,044
1,207
Income from Continuing Operations
-606,639
-606,639
-707,421
-454,025
-186,566
Net Income
-606,639
-606,639
-707,421
-454,025
-186,566
Net Income available to common shareholders
-606,639
-606,639
-707,421
-454,025
-186,566
Basic EPS
-8.97
-
-10.12
-6.70
-3.07
Diluted EPS
-8.97
-
-10.12
-6.70
-3.07
Basic Average Shares
70,780
-
69,914
67,796
60,846
Diluted Average Shares
70,780
-
69,914
67,796
60,846